openPR Logo
Press release

Histone Deacetylase Inhibitors Market 2020 Growth Projection by Leading Players: Abcam plc., Cetya Therapeutics, RandD Systems, Inc., Mirati Therapeutics, TCI Chemicals (India) Pvt. Ltd., InvivoGen, BioVision Inc., Medivir AB, and Merck KGaA

Histone Deacetylase Inhibitors Market 2020 Growth Projection

Global Histone Deacetylase Inhibitors Market Size, Share and Global Trend By Class (Class I HDACs, Class II HDACS, Class III HDACs, Class IV HDACs), Application (Oncology, Neurology), End User (Hospitals, Academic & research institutes, Pharmaceutical companies) and Geography Forecast till 2026.

To know How COVID-19 Pandemic Will Impact This Market/Industry -Request a sample copy of the report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/histone-deacetylase-inhibitors-market-100323

Histone Deacetylase Inhibitors Market Key Companies Analyzed:

Abcam plc., Cetya Therapeutics, RandD Systems, Inc., Mirati Therapeutics, TCI Chemicals (India) Pvt. Ltd., InvivoGen, BioVision Inc., Medivir AB, and Merck KGaA.

Global Histone Deacetylase Inhibitors Market Highlights:

Various factors are responsible for the growth of the global histone deacetylase market including the increasing number of cancer cases. Other factors include the presence of skilled professionals in developed regions, increasing number of neurological disorders and tumor cases, and supportive reimbursement policies by governments. As per the World Health Organization, the second major cause of death in the world is cancer. In 2018, cancer was the cause of death in an estimated 9.6 million people around the world.

On the flipside, the market may face challenges in terms of inadequate reimbursement policies. However, rise in awareness about various chronic diseases and the availability of advanced diagnostics for timely diagnosis of such diseases will help the market gain momentum in the coming years.

According to Fortune Business Insights, the cancer segment will account for the largest share in the market, due to its rising prevalence. Increasing expenditure on healthcare especially for treatment of cancer is helping the cancer segment lead the market.

Regional Analysis:

From a geographical standpoint, the global histone deacetylase inhibitors market is dominated by North America on account of rising prevalence of neurological disorders and cancer. The American Cancer Society states an estimated 12% of women in the U.S. develop breast cancer during their lifetime. The report also stated an estimate of 2300 men in the U.S. to be diagnosed with breast cancer. This, coupled with, the high acceptance of histone deacetylase inhibitors in developed nations of Canada and the U.S. is likely to help North America continue dominating the market through the forecast period.

On the other hand, markets at Europe and Asia Pacific are anticipated to grow at a faster rate owing to the increasing cases of neurological disorders and the improving healthcare facilities in the respective regions. Besides this, the surge in demand for advanced treatment by a large number of patients is a major factor propelling growth of the market.

Market Segments Analysis:

The Histone Deacetylase Inhibitors Market can be segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;

Segmentation by Class - Class I HDACs, Class II HDACS, Class III HDACs, Class IV HDACs

Segmentation by Application - Oncology, Neurology

Segmentation by End User - Hospitals, Academic and research institutes, Pharmaceutical companies

Segmentation by Regions: North America, Europe, APAC and Rest of the World.

Histone Deacetylase Inhibitors Market Report Covers Major Insights:

Key drivers, restraints, and prevailing Histone Deacetylase Inhibitors Market trends
Histone Deacetylase Inhibitors Market size, growth rate, and opportunities
Histone Deacetylase Inhibitors Market share and position of the top players
PEST Analysis of the five major regions
Detailed SWOT analysis of top companies
Recent developments and new product launches
Major challenges faced by the market players
Histone Deacetylase Inhibitors Market report also include data type such as capacity, production, market share, price, growth rate, consumption, import, export etc. Industry chain, manufacturing process, cost structure, marketing channel are also analysed in this report.

Market Segment by Regional Analysis covers:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
The global Histone Deacetylase Inhibitors market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2024. In 2020, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Table of Contents

1 Market Overview

1.1 Histone Deacetylase Inhibitors Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.4 South America, Middle East and Africa

1.5 Market Dynamics

Click here to get the short-term and long-term impact of COVID-19 on this Histone Deacetylase Inhibitors Market: https://www.fortunebusinessinsights.com/industry-reports/histone-deacetylase-inhibitors-market-100323

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights Pvt. Ltd.

Supreme Headquarters,

Pune Banglore Highway, Baner, Pune,

Maharashtra 411045, India

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Pune Banglore Highway Pashan Exit, Baner, Pune, Maharashtra 411045, India

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Histone Deacetylase Inhibitors Market 2020 Growth Projection by Leading Players: Abcam plc., Cetya Therapeutics, RandD Systems, Inc., Mirati Therapeutics, TCI Chemicals (India) Pvt. Ltd., InvivoGen, BioVision Inc., Medivir AB, and Merck KGaA here

News-ID: 2021999 • Views: 343

More Releases from Fortune Business Insights Pvt. Ltd

Offshore Drilling Market To Boom Industry Size: 2022, Growth Perspectives, Devel …
The global offshore drilling market size stood at USD 31.26 billion in 2018 and is projected to reach USD 56.97 billion by 2026, exhibiting a CAGR of 7.9% during the forecast period. | 2022 Energy And Power Industry Global Analysis by Covid-19 Impact On, Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2029 is latest study published by Fortune Business Insights. Request a
Essential Oils Market Development, Revenue, Future Growth and Forecast to 2029
The global essential oils market size is set to gain traction by reaching USD 18.25 billion by 2028 while exhibiting a CAGR of 9.57% in the forecast period. This information is given by Fortune Business Insights™ in its report, titled, "Essential oils Market, 2021-2028." The report further observes that the market stood at USD 8.74 billion in 2020. The rising trend of green consumerism and natural inputs for food preservation
Bubble Tea Market Growth, Industry Striking Revenue Forecast by 2027
The global bubble tea market growth is set to gain traction from its possession of numerous health benefits. Boba tea acts as an antioxidant. It is also preferred by health-conscious consumers owing to its low-fat and low-calorie content. Fortune Business Insights™ published this information in a new report, titled, "Bubble Tea Market Size, Share & Covid-19 Impact Analysis, By Type (Black Tea, Green Tea, Oolong Tea, and White Tea), Flavor
Aerospace Additive Manufacturing Market Share, Size, Trend, Demand, Analysis by …
The global aerospace additive manufacturing market size is expected to grow substantially because of the rising demand for complex aircraft parts. The incorporation of the manufacturing technique is expected to facilitate market development. Fortune Business Insights™ mentions this information in its report titled "Aerospace Additive Manufacturing Market, 2021-2028." Aerospace additive manufacturing is a 3D printed aircraft component manufacturing technique that effectively produces customizable parts using lightweight and durable components. It reduces

All 5 Releases


More Releases for Histone

Global Histone Deacetylase Inhibitors Market Research Report
This report studies the global Histone Deacetylase Inhibitors market status and forecast, categorizes the global Histone Deacetylase Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 4SC AG Acetylon Pharmaceuticals Celleron Therapeutics Chroma Therapeutics CrystalGenomics Curis MEI Pharma Mirati Therapeutics Novartis
Histone Methyltransferases Market Growth Analysis 2019
Histones are the major protein constituents of eukaryotic nucleus. Histone methyltransferases catalyzes the transfer of methyl group to lysine and arginine residues of the histone protein. It catalyzes the reaction with the help of SN-2 mechanism where transfer of methyl group from S Adenosyl Methionine to amino group of target lysine takes place. There are seven histone methyltransferase includes EZ, SET1, SET2, SMYD, SUV39, SUV4-20 and RIZ. The main function
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase Inhibitors Market & Pipeline Insight2015
Histone Deacetylase (HDAC) are enzymes responsible for removal of acetyl groups present on acetyl lysine amino acid attached to histone. They are responsible for gene expression and regulation which is responsible for cellular functioning. It also helps in wrapping of histone over the Deoxyribonucleic acid (DNA). They are involved in cell growth and death which is responsible for maintaining steady state. Their involvement in diseases has been noted by investigators